Despite Uptake Barriers, Real-World Biosimilar Data Demonstrate Safety, Efficacy, Cost-Effectiveness
AJMC,
Biosimilars were a recurring subject at The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Biosimilars were a recurring subject at The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
In the final part of an interview with HCPLive Rheumatology, Juliana Reed, MS, executive director of the Biosimilars Forum…
A peer-reviewed report, “Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence…
The recent publication of a peer-reviewed report by the Biosimilars Forum delved into the future trajectory of biosimilar…